<DOC>
	<DOCNO>NCT02452892</DOCNO>
	<brief_summary>The purpose study compare relative effectiveness 20 60 minute Low-Field Magnetic Stimulation relieve symptom patient major depression treatment resistant .</brief_summary>
	<brief_title>Low Field Magnetic Stimulation ( LFMS ) Subjects With Treatment-Resistant Depression ( TRD )</brief_title>
	<detailed_description>The primary objective study : - To compare relative efficacy , measure change 6-item Hamilton Rating Scale Depression ( HAM-D6 ) , 20 60 minute LFMS compare sham ( placebo ) subject treatment resistant depression ( TRD ) . Secondary objective : - To determine subject TRD may respond 120 minute LFMS . - To determine persistence response LFMS therapy observation period . - To evaluate safety tolerability LFMS .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<criteria>( Key ) Meets Diagnostic Statistical Manual Mental Disorder , 5th Edition ( DSM5 ) criteria Major Depressive Disorder ( MDD ) , determine psychiatric evaluation . Has TRD current MDE , assess site Massachusetts General Hospital/Antidepressant Treatment Response Questionnaire ( MGH/ATRQ ) . On adequate dose one antidepressant therapy ( ADT ) least eight week prior screen visit ( Visit 1 ) . The ADT dose must stable least four week prior screen visit ( Visit 1 ) . Subjects must willing remain stable dose ADT upon sign informed consent form end treatment observation period ( end Week 2 ) , possible , end study participation ( Key ) Have fail four lifetime adequate ADT treatment regimen ( include ongoing ADT current MDE ) . Have treat adjunctive antipsychotic medication antidepressant least two week current depressive episode . Are deem significant risk suicidal behavior Are unable lie back duration study treatment Have lifetime history : 1 . Delirium , dementia , amnestic , cognitive disorder ; 2 . Schizophrenia psychotic disorder , base Structured Clinical Interview DSM5 Axis I Disorders Patient Edition ( SCIDI/P ) ; 3 . Bipolar I II disorder , base SCIDI/P . Have current DSM5 diagnosis screen visit ( Visit 1 ) : 1 . An eating disorder active within 12 month prior screen visit ( Visit 1 ) ; 2 . Comorbid anxiety disorder predominate MDD , assess investigator ; 3 . Alcohol substance use disorder active within 12 month prior screen visit ( Visit 1 ) ; 4 . Clinically significant DSM5 Axis II disorder . Have ever receive electroconvulsive therapy , vagal nerve stimulation , deep brain stimulation repetitive transcranial magnetic stimulation . Have nonremovable programmable device appliance cardiac pacemaker cochlear implant . Have nonremovable ferromagnetic implant , conductive magnetic sensitive material present head neck . Have lifetime history seizure clinically significant electroencephalography abnormality . A history childhood febrile seizure permit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Major depression</keyword>
	<keyword>Low-field magnetic stimulation</keyword>
	<keyword>LFMS</keyword>
</DOC>